Go Pro

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$27.08
+1.7%
$23.41
$5.26
$31.31
$285.72M0.6574,724 shs33,438 shs
PARK
Park Dental Partners
$20.98
+4.0%
$20.38
$9.53
$26.79
$99.87MN/A33,916 shs236,389 shs
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
$10.48
-0.1%
$10.48
$10.11
$10.65
$341.91M0.0886,528 shs59,435 shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$8.76
-0.3%
$10.49
$6.05
$12.61
$333.65M1.09297,354 shs399,396 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
+1.72%+6.22%+13.32%+77.42%+208.07%
PARK
Park Dental Partners
-1.22%-4.22%-4.63%+12.99%+2,017,999,900.00%
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
-0.10%-0.05%+0.43%+0.91%+1.70%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
-3.19%-0.11%-9.66%-13.23%+27.95%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Biodesix, Inc. stock logo
BDSX
Biodesix
$27.08
+1.7%
$23.41
$5.26
$31.31
$285.72M0.6574,724 shs33,438 shs
PARK
Park Dental Partners
$20.98
+4.0%
$20.38
$9.53
$26.79
$99.87MN/A33,916 shs236,389 shs
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
$10.48
-0.1%
$10.48
$10.11
$10.65
$341.91M0.0886,528 shs59,435 shs
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$8.76
-0.3%
$10.49
$6.05
$12.61
$333.65M1.09297,354 shs399,396 shs
The Infrastructure's Backbone: 10 Stocks Powering the AI Buildout Cover

The AI boom extends far beyond the biggest tech names. Discover 10 companies supplying the memory, storage, networking, semiconductor manufacturing, and power infrastructure that make AI possible. Learn where the next wave of AI investment opportunities may emerge—and the key risks investors should watch as the global AI buildout accelerates.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Biodesix, Inc. stock logo
BDSX
Biodesix
+1.72%+6.22%+13.32%+77.42%+208.07%
PARK
Park Dental Partners
-1.22%-4.22%-4.63%+12.99%+2,017,999,900.00%
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
-0.10%-0.05%+0.43%+0.91%+1.70%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
-3.19%-0.11%-9.66%-13.23%+27.95%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Biodesix, Inc. stock logo
BDSX
Biodesix
2.80
Moderate Buy$31.3314.77% Upside
PARK
Park Dental Partners
2.50
Moderate Buy$28.5037.71% Upside
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
1.00
SellN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
2.25
Hold$14.0061.85% Upside

Current Analyst Ratings Breakdown

Latest PARK, VMD, TACO, and BDSX Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
9/1/2026
PARK
Park Dental Partners
UpgradeSell (E+)Sell (D-)
8/24/2026
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
UpgradeSell (D-)Sell (D)
8/24/2026
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
Initiated CoverageOutperform$14.00
8/21/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
DowngradeSell (D-)Sell (E+)
8/17/2026
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
DowngradeBuy (B-)Hold (C+)
8/14/2026
PARK
Park Dental Partners
Reiterated RatingBuy$30.00
8/13/2026
PARK
Park Dental Partners
Set Price Target$27.00
8/10/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
Boost Price TargetBuy$27.00 ➝ $35.00
8/6/2026
Biodesix, Inc. stock logo
BDSX
Biodesix
Reiterated RatingBuy$26.00 ➝ $27.00
8/5/2026
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
DowngradeStrong-BuyHold
8/3/2026
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
UpgradeHold (C+)Buy (B-)
(Data available from 9/9/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Biodesix, Inc. stock logo
BDSX
Biodesix
$102.94M2.80N/AN/A($0.31) per share-88.06
PARK
Park Dental Partners
$244.49M0.40$4.45 per share4.65$5.33 per share3.88
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
N/AN/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$301.61M1.09$1.10 per share7.89$3.78 per share2.29
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Biodesix, Inc. stock logo
BDSX
Biodesix
-$35.26M-$3.17N/AN/AN/A-26.97%-788.19%-30.33%11/2/2026 (Estimated)
PARK
Park Dental Partners
-$360K$1.0519.7720.09N/AN/AN/AN/AN/A
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
N/AN/AN/AN/AN/AN/AN/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$14.93M$0.3623.9318.022.244.81%10.16%7.22%11/4/2026 (Estimated)

Latest PARK, VMD, TACO, and BDSX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2026Q2 2026
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
N/A$0.03N/A$0.03N/AN/A
8/12/2026Q2 2026
PARK
Park Dental Partners
$0.04$0.66+$0.62$0.22N/A$66.21 million
8/5/2026Q2 2026
Biodesix, Inc. stock logo
BDSX
Biodesix
-$0.9018-$0.71+$0.1918-$0.71$26.03 million$26.86 million
8/3/2026Q2 2026
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
$0.12$0.07-$0.05$0.07$78.00 million$78.10 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Biodesix, Inc. stock logo
BDSX
Biodesix
N/AN/AN/AN/AN/A
PARK
Park Dental Partners
N/AN/AN/AN/AN/A
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
$0.161.52%N/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Biodesix, Inc. stock logo
BDSX
Biodesix
5.12
2.85
2.85
PARK
Park Dental Partners
0.31
1.12
1.12
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
N/AN/AN/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
0.04
1.13
1.02

Institutional Ownership

CompanyInstitutional Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
20.96%
PARK
Park Dental Partners
N/A
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
N/A
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
74.24%

Insider Ownership

CompanyInsider Ownership
Biodesix, Inc. stock logo
BDSX
Biodesix
23.20%
PARK
Park Dental Partners
10.56%
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
13.20%
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
20.60%
CompanyEmployeesShares OutstandingFree FloatOptionable
Biodesix, Inc. stock logo
BDSX
Biodesix
22010.55 million8.10 millionNo Data
PARK
Park Dental Partners
1,2124.76 million4.25 millionN/A
Berto Acquisition Corp. stock logo
TACO
Berto Acquisition
7,89232.63 millionN/ANo Data
Viemed Healthcare, Inc. stock logo
VMD
Viemed Healthcare
1,38238.09 million30.24 millionNot Optionable

Recent News About These Companies

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Biodesix stock logo

Biodesix NASDAQ:BDSX

$27.08 +0.45 (+1.69%)
Closing price 04:00 PM Eastern
Extended Trading
$27.19 +0.11 (+0.41%)
As of 04:38 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Biodesix, Inc. operates as a data-driven diagnostic solutions company in the United States. The company offers blood-based lung tests, including Nodify XL2 and Nodify CDT tests, together marketed as part of Nodify Lung Nodule Risk Assessment testing strategy, to assess the risk of lung cancer and help in identifying the appropriate treatment pathway and help physicians in reclassifying risk of malignancy in patients with suspicious lung nodules. It also provides GeneStrat ddPCR and NGS, and VeriStrat tests, which are used in the diagnosis of lung cancer to measure the presence of mutations in the tumor and the state of the patient's immune system to establish the patient's prognosis and help guide treatment decisions. In addition, the company, through its partnership with Bio-Rad Laboratories, Inc., provides Bio-Rad SARS-CoV-2 ddPCR, a COVID-19 Test under Biodesix WorkSafe testing program; and Platelia SARS-CoV-2 Total Ab test, an antibody test for detecting a B-cell immune response to SARS-CoV-2 that indicate recent or prior infection. Further, it offers diagnostic and clinical research, as well as clinical trial testing services to biopharmaceutical companies; and discovers, develops, and commercializes companion diagnostics. The company was formerly known as Elston Technologies, Inc. and as changed to Biodesix, Inc. in 2006. Biodesix, Inc. was incorporated in 2005 and is headquartered in Louisville, Colorado.

Park Dental Partners NASDAQ:PARK

$20.98 +0.80 (+3.96%)
Closing price 04:00 PM Eastern
Extended Trading
$21.05 +0.07 (+0.33%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

As a dental resource organization (“DRO”) operating through Park Dental Partners, Inc., and subsidiaries, we provide comprehensive business support services including clinical team members, administrative personnel, facilities and equipment to our affiliated general and multi-specialty dental practices (which are not legal subsidiaries) throughout Minnesota and Wisconsin. Our network of affiliated dental practices employs over 200 dentists across 84 practice locations and was ranked as one of Minnesota’s largest private companies by revenue by the Minneapolis/St Paul Business Journal in June 2025. Our clinical support team includes over 900 hygienists, dental assistants, and patient care coordinators that support affiliated dentists in operating their dental practices. Our network of affiliated dental practices has been operating for over fifty years, beginning with the establishment of the general dentistry group in 1972. The mission of our affiliated dental practices since inception has been to ensure patients enjoy the benefits of a lifetime of good oral health. This mission continues to be the driving force behind our organization today. Our network of affiliated dental practices provides both general and specialty dental services, including oral surgery, periodontics, pediatric dentistry, prosthodontics, endodontics, and orthodontics, under long-term agreements with initial terms of 30 years, with automatic 5-year renewals. We have established a significant footprint and brand awareness in our current markets. Our revenues, derived primarily from our affiliated dental practices’ provision of dental services, were approximately $183.3 million and $172.9 million for the nine months ended September 30, 2025 and 2024, respectively, and were approximately $229.8 million and $223.5 million for the years ended December 31, 2024 and 2023, respectively. Our material revenues are comprised of dental services, which includes the consolidated revenues of our affiliated dental practices. Dental services are provided to patients, who typically pay for services through private insurance plans, government insurance plans, or directly. Approximately 91% and 93% of total revenues for each of the nine months ended September 30, 2025, and 2024, respectively, and approximately 93% of total revenues for each of the years ended December 31, 2024 and 2023, respectively, were derived from patients with private insurance or government sponsored plans. Dental care patients tend to be price-sensitive because many pay for a significant portion of their dental expenses on an out-of-pocket basis. We have steadily grown by adding new dentists and team members, expanding existing practices, implementing operating efficiencies, and by acquiring existing practices. Our organic expansion includes opening de novo practices, which are new practice locations opened with our affiliated dentists in existing or new markets. Since the start of calendar 2014 we have acquired 40 practices and opened 11 de novo practices. On average, de novo practices are cash flow positive within approximately six months, meaning that the practice location monthly Gross Margin excluding depreciation is positive. Of the 11 de novo practices opened since 2014, more than 80% were cash flow positive within six months. We attribute this success to our established model that streamlines day-to-day dental practice operations by providing key business and administrative resources, allowing dentists and team members to focus on patient care. We plan to expand our existing general and multi-specialty dental brands, establishing a group of successful, respected dental practices. Dentists hold a majority interest in our organization, which we believe is a key differentiator between our model and those of our competitors. Our model provides our affiliated dentists with significant organizational input because our affiliated dentists, who are majority shareholders in the business, are directly involved in our governance through their right to appoint three directors to the Board of Directors. We believe this right helps ensure that our affiliated dentists maintain a professional voice in governance that helps focus the organization on ensuring patients enjoy the benefits of a lifetime of good oral health. We believe this compelling model allows for greater input and provides enhanced stewardship for dentists, which assists with attracting and retaining dental professionals and serves as a catalyst for future growth. By contrast, we believe traditional dental organization ownership structures, many of which are funded by private equity, introduce constraints and concessions that limit dentists’ clinical autonomy and can restrict or omit dentists’ professional voice in governance. --- Our affiliated dental practices have been in operation since the founding of Park Dental in 1972. In May 2023, the owners of our affiliated dental practices established a dental resource organization 100% owned by dentists and management, through the creation of Park Dental Partners, Inc. and transitioned to the new operating structure on October 1, 2023. Park Dental Partners, Inc was incorporated in the state of Minnesota in 2023 to act as a dental resource organization for the operating affiliated dental practices. Our principal executive offices are located in Roseville, Minnesota.

Berto Acquisition stock logo

Berto Acquisition NASDAQ:TACO

$10.48 -0.01 (-0.10%)
Closing price 03:59 PM Eastern
Extended Trading
$10.48 +0.00 (+0.05%)
As of 04:10 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Del Taco Restaurants, Inc. develops, franchises, owns, and operates Del Taco quick-service Mexican-American restaurants in the United States. The company's restaurants offer Mexican inspired and American classic dishes. As of August 31, 2021, it operated approximately 600 restaurants across 16 states. The company was founded in 1964 and is headquartered in Lake Forest, California.

Viemed Healthcare stock logo

Viemed Healthcare NASDAQ:VMD

$8.76 -0.03 (-0.34%)
Closing price 04:00 PM Eastern
Extended Trading
$8.75 -0.01 (-0.11%)
As of 05:35 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Viemed Healthcare, Inc., together with its subsidiaries, provides home medical equipment (HME) and post-acute respiratory healthcare services to patients in the United States. It provides respiratory disease management solutions, including treatment of chronic obstructive pulmonary disease (COPD), which include non-invasive ventilation, percussion vests, and other therapies; and invasive and non-invasive ventilation and related equipment and supplies to patients suffering from COPD. The company leases non-invasive and invasive ventilators, positive airway pressure machines (PAP), durable medical equipment, percussion vests, oxygen concentrators, and other medical equipment; and sells and rents HME devices. In addition, it provides neuromuscular care and oxygen therapy services; and sleep apnea management provides sleep solutions and/or equipment, such as PAP, automatic continuous positive airway pressure, and bi-level positive airway pressure machines. Further, the company offers in home sleep apnea testing services, as well as healthcare staffing and recruitment services. Viemed Healthcare, Inc. was founded in 2006 and is headquartered in Lafayette, Louisiana.